Melanosis: Clinical Trials

221 trials for Melanosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

107 completed, 55 unknown, 20 not yet recruiting, 13 recruiting. 110 Not applicable, 31 Phase 2, 29 Phase 4, 14 Phase 3, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable110Completed 53, Unknown 29, Not yet recruiting 12, Recruiting 6, Active not recruiting 5, Terminated 3, Withdrawn 2
Phase 231Completed 16, Unknown 4, Not yet recruiting 3, Recruiting 2, Terminated 2, Withdrawn 2, Enrolling by invitation 1, Suspended 1
Phase 429Unknown 12, Completed 10, Not yet recruiting 3, Terminated 2, Active not recruiting 1, Enrolling by invitation 1
Phase 314Completed 6, Unknown 5, Not yet recruiting 1, Recruiting 1, Suspended 1
Phase 111Completed 5, Withdrawn 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Early Phase 15Completed 3, Unknown 1, Withdrawn 1

Follow Melanosis: new trials by email Literature Review of Melanosis trials Research Report on Melanosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
Tranexamic acid, Standardised sunscreen and emollient - Melasma
Phase 4Not yet recruitingAllied Hospital Faisalabad1282026-11-012026-10-19
COMPARISON OF TOPICAL VITAMIN C VS NIACINAMIDE IN TREATMENT OF MELASMA
Ascorbic acid, niacinamide - Melasma
Not applicableNot yet recruitingPak Emirates Military Hospital1002026-11-012026-10-22
New Treatment in Melasma
Tranexamic Acid - topical, Microneedling with Topical Tranexamic acid, Modified Kligman's Formula - Female, With
Not applicableNot yet recruitingSohag University752026-10-182026-10-21
Chinese Multicenter Registry for Peutz-Jeghers Syndrome
Peutz-Jeghers Syndrome
Not yet recruitingFirst People's Hospital of Hangzhou10002026-10-012026-10-22
Topical Metformin Versus Triple Regimen for Epidermal Melasma
Topical 30% metformin cream, Topical Triple Regimen - Epidermal Melasma, Facial Hyperpigmentation
Phase 2Not yet recruitingCombined Military Hospital, Pakistan1042026-08-152026-08-21
Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma
Ligustrazine - tranexamic acid - aloe polysaccharide composite gel - Melasma, Treatment of Stable Melasma
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College102026-08-122026-04-14
Efficacy and Safety Of Fractional Carbon Dioxide Laser Plus Topical Metformin In Treatment Of Acanthosis Nigricans
Topical metformin - Acanthosis Nigricans
Phase 1Not yet recruitingAl-Azhar University342026-08-102026-08-12
Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma
Oral tranexamic acid + triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin), Triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin) alone - Melasma, Melasma (Facial Melasma)
Phase 4Not yet recruitingCombined Military Hospital Abbottabad1282026-07-152026-07-28
Efficacy Evaluation of a Cosmetic Product for Facial Hyperpigmentation
Blancy Pro - Hyperpigmentation, Melasma (Facial Melasma)
Not applicableRecruitingBrainfarma Industria Química e Farmacêutica S/A402026-07-132026-09-16
Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma
Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma)
Phase 4Enrolling by invitationSameh Sarsik802026-07-102026-07-28
Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma
Topical 30% metformin cream, Kligman's Regimen - Melasma (Facial Melasma), Melasma
Not applicableNot yet recruitingFoundation University Islamabad822026-07-012026-03-20
Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma
topical 3% tranexamic acid solution, Topical 30% metformin cream - Melasma
Not applicableNot yet recruitingFoundation University Islamabad702026-07-012026-03-27
Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma
Topical azelaic acid 12% plus tranexamic acid 5%, Placebo topical formulation - Melasma
Not applicableCompletedUniversity of Guadalajara402026-06-122026-07-27
A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants
Sunscreen untinted, Sunscreen tinted - Post-inflammatory Hyperpigmentation, Melasma
Not applicableRecruitingKenvue Brands LLC1522026-06-022026-07-01
Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma
Ethyl ascorbic acid topical application, Tranxemic acid topical application - Melasma
Phase 4Not yet recruitingHayatabad Medical Complex1282026-06-012026-04-13
Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study
Melasma, Melasma (Facial Melasma)
Enrolling by invitationVenus Research Center152026-06-012025-12-29
Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel in the Treatment of Melasma
Mandelic Acid Peel, Intralesional Tranexamic Acid - Melasma
Not applicableNot yet recruitingCombined Military Hospital Abbottabad1202026-05-012026-05-28
Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions
Glycolic acid peel alone, MelaB3 serum - Hyperpigmentation, Melasma
Not applicableNot yet recruitingCosmetique Active International802026-03-042026-02-24
Secretome TGF Beta 3
Concentrated secretome Injection 3 mL, Concentrated secretome Injection 3 mL with addition of TGF Beta 3 - Melasma
Not applicableNot yet recruitingUniversitas Indonesia342026-02-142025-08-22
Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma
microneedling, Oral tranexamic acid, Glutathione - Melasma
Phase 2 / Phase 3Not yet recruitingAssiut University422026-02-012026-03-04

Showing 20 of 221. Sign in to see all of them.

Narrower conditions

Hyperpigmentation (30)  ·  Peutz-Jeghers Syndrome (22)  ·  Acanthosis Nigricans (18)  ·  Lentigo (13)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (9)  ·  Pancreatic Neoplasms (7)  ·  Obesity (6)  ·  Pigmentation Disorders (6)  ·  Dysplastic Nevus Syndrome (4)  ·  Hereditary pancreatitis (4)  ·  Keratosis, Actinic (4)  ·  Melanoma (4)  ·  Skin Diseases (4)  ·  Acne Vulgaris (3)

Broader conditions

Skin and Connective Tissue Diseases (221)  ·  Skin Diseases (217)  ·  Pigmentation Disorders (215)  ·  Hyperpigmentation (191)  ·  Neoplasms (29)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (24)  ·  Lentigo (24)  ·  Digestive System Diseases (23)  ·  Genetic Diseases, Inborn (23)  ·  Neoplastic Syndromes, Hereditary (23)  ·  Gastrointestinal Diseases (22)  ·  Intestinal Diseases (22)  ·  Intestinal Polyposis (22)

Interventions

Tranexamic Acid (22)  ·  hydroquinone (19)  ·  Tretinoin (10)  ·  Metformin (9)  ·  Fluocinolone Acetonide (5)  ·  Percutaneous Collagen Induction (5)  ·  Lasers (4)  ·  Saline Solution (4)  ·  Sunscreening Agents (4)  ·  3-ingenyl angelate (3)  ·  Lasers, Solid-State (3)  ·  Melatonin (3)  ·  Niacinamide (3)  ·  Secretin (3)  ·  Trichloroacetic Acid (3)

Sponsors

Assiut University (11)  ·  Cosmetique Active International (9)  ·  Centre Hospitalier Universitaire de Nice (6)  ·  Universidad Autonoma de San Luis Potosí (6)  ·  Combined Military Hospital Abbottabad (5)  ·  Northwestern University (5)  ·  Universitas Indonesia (5)  ·  Cairo University (4)  ·  Dr.dr.Irma Bernadette, SpKK (K) (4)  ·  Galderma R&D (4)  ·  Jinnah Postgraduate Medical Centre (4)  ·  Cryonove Pharma (3)  ·  Cynosure, Inc. (3)  ·  CynosureLutronic (3)  ·  Goldman, Butterwick, Fitzpatrick and Groff (3)

Countries

United States (56)  ·  China (20)  ·  Pakistan (20)  ·  Egypt (14)  ·  Mexico (11)  ·  Brazil (10)  ·  Indonesia (10)  ·  France (9)  ·  Singapore (4)  ·  Thailand (4)  ·  India (3)  ·  Italy (2)  ·  Netherlands (2)  ·  Taiwan (2)  ·  Australia (1)

Top investigators

Murad Alam, MD (5)  ·  Bertha Torres-Alvarez, MD (3)  ·  Juan P Castanedo-Cazares, MD (3)  ·  Irma B Sitohang, MD, PhD (2)  ·  Kari Larson, MBA (2)  ·  Patricia Krantz (2)  ·  Ronald W Gottschalk, MD (2)  ·  Sergio Schalka (2)  ·  Thierry Passeron, PhD (2)  ·  Adriana Rodriguez-Arambula, MD (1)  ·  Aimee Lucas, MD, MS (1)  ·  Alaa H Ghazally, MD (1)  ·  Albert Wolkerstorfer, MD PhD (1)

Results publications

PMID 25184917, PMID 25068546, PMID 28726212, PMID 11096382, PMID 16631967, PMID 18021205, PMID 18419607, PMID 20083690, PMID 20398959, PMID 20458532, PMID 20514787, PMID 21384391, PMID 21920241, PMID 21920242, PMID 22154461, PMID 23200980, PMID 24292155, PMID 24629163, PMID 24746304, PMID 24756109, PMID 24854088, PMID 24858737, PMID 25396122, PMID 25396123, PMID 25481712, PMID 25715311, PMID 25787765, PMID 26367281, PMID 26381025, PMID 26479922, PMID 26955093, PMID 27206758, PMID 28748406, PMID 28842328, PMID 29020467, PMID 29371475, PMID 29386825, PMID 29706998, PMID 30215845, PMID 30320904, PMID 30422338, PMID 30538291, PMID 30586845, PMID 30646266, PMID 30779300, PMID 31097585, PMID 31116404, PMID 31197699, PMID 31354327, PMID 31421157

NIH funding

2018 (1), 2019 (1), M01RR006022 (1), R01CA176828 (1), U01CA210170 (1)